Department of Health and Human Services December 27, 2005 – Federal Register Recent Federal Regulation Documents

National Center for Environmental Health/Agency for Toxic Substances and Disease Registry; Meetings
Document Number: E5-7868
Type: Notice
Date: 2005-12-27
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Proposed Data Collections Submitted for Public Comment and Recommendations
Document Number: E5-7863
Type: Notice
Date: 2005-12-27
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Proposed Data Collections Submitted for Public Comment and Recommendations
Document Number: E5-7862
Type: Notice
Date: 2005-12-27
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Proposed Data Collections Submitted for Public Comment and Recommendations
Document Number: E5-7861
Type: Notice
Date: 2005-12-27
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Final Effect of Designation of a Class of Employees for Addition to the Special Exposure Cohort
Document Number: E5-7811
Type: Notice
Date: 2005-12-27
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
The Department of Health and Human Services (HHS) gives notice concerning the final effect of the HHS decision to designate a class of employees at the Mallinckrodt Chemical Works, Destrehan Street Facility, in St. Louis, Missouri, as an addition to the Special Exposure Cohort (SEC) under the Energy Employees Occupational Illness Compensation Program Act of 2000. On October 14, 2005, as provided for under 42 U.S.C. 7384q(b), the Secretary of HHS designated the following class of employees as an addition to the SEC:
Designation of a Class of Employees for Addition to the Special Exposure Cohort
Document Number: E5-7810
Type: Notice
Date: 2005-12-27
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
The Department of Health and Human Services (HHS) gives notice of a decision to designate a class of employees at the Linde Ceramics Plant, in Tonawanda, New York as an addition to the Special Exposure Cohort (SEC) under the Energy Employees Occupational Illness Compensation Program Act of 2000. On December 8, 2005, the Secretary of HHS designated the following class of employees as an addition to the SEC:
Decision To Evaluate a Petition To Designate a Class of Employees at Chapman Valve Co., Indian Orchard, Massachusetts, To Be Included in the Special Exposure Cohort
Document Number: E5-7809
Type: Notice
Date: 2005-12-27
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
The Department of Health and Human Services (HHS) gives notice as required by 42 CFR 83.12(e) of a decision to evaluate a petition to designate a class of employees at the Chapman Valve Co., in Indian Orchard, Massachusetts, to be included in the Special Exposure Cohort under the Energy Employees Occupational Illness Compensation Program Act of 2000. The initial proposed definition for the class being evaluated, subject to revision as warranted by the evaluation, is as follows: Facility: Chapman Valve Co. Location: Indian Orchard, Massachusetts. Job Titles and/or Job Duties: Various. Period of Employment: From 1948 through 1949 and from 1991-1995 (DOE Remediation).
Employment and Training Administration Determination Concerning a Class of Employees Considered for Addition to the Special Exposure Cohort
Document Number: E5-7807
Type: Notice
Date: 2005-12-27
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
The Department of Health and Human Services (HHS) gives notice of a decision that a class of employees at the National Bureau of Standards, Van Ness Street, Washington, DC, do not meet the statutory criteria for addition to the Special Exposure Cohort (SEC) under the Energy Employees Occupational Illness Compensation Program Act of 2000 (EEOICPA). On December 8, 2005, the Secretary of HHS determined, based on the decision by the Department of Energy to remove the site from the list of covered facilities, that the following class of employees do not meet the statutory requirements for covered employees under EEOICPA and thus do not meet the statutory requirements for the SEC:
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Reclassification Petitions for Medical Devices
Document Number: E5-7804
Type: Notice
Date: 2005-12-27
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Guidance for Industry: Questions and Answers Regarding Food Allergens, Including the Food Allergen Labeling and Consumer Protection Act of 2004 (Edition 2); Availability
Document Number: E5-7803
Type: Notice
Date: 2005-12-27
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing the availability of a revised guidance document entitled ``Guidance for Industry: Questions and Answers Regarding Food Allergens, including the Food Allergen Labeling and Consumer Protection Act of 2004 (Edition 2).'' The guidance explains, using a question and answer format, FDA's current thinking on a number of issues related to the regulation of food allergens, including implementation of the Food Allergen Labeling and Consumer Protection Act (FALCPA).
Health Resources and Services Administration Statement of Organization, Functions and Delegations of Authority
Document Number: E5-7800
Type: Notice
Date: 2005-12-27
Agency: Department of Health and Human Services, Health Resources and Services Administration
Draft Guidance for Industry: Lead in Candy Likely To Be Consumed Frequently by Small Children: Recommended Maximum Level and Enforcement Policy; Draft Supporting Document: Supporting Document for Recommended Maximum Level for Lead in Candy Likely To Be Consumed Frequently by Small Children; Availability
Document Number: 05-24494
Type: Notice
Date: 2005-12-27
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled ``Lead in Candy Likely To Be Consumed Frequently by Small Children: Recommended Maximum Level and Enforcement Policy.'' This draft guidance provides a recommended maximum lead level in candy likely to be consumed frequently by small children. FDA considers the recommended maximum level to be protective of human health and to be achievable with the use of good manufacturing practices in the production of candy and candy ingredients. The agency is also announcing the availability of a draft supporting document entitled ``Supporting Document for Recommended Maximum Level for Lead in Candy Likely To Be Consumed Frequently by Small Children.'' These two documents are intended to assist candy manufacturers in achieving reduced lead levels in their products consistent with the agency's policy of reducing lead levels in the food supply to reduce consumers' lead exposure to the lowest level that practicably can be obtained.
Healthy Tomorrows Partnership for Children Program (HTPC)
Document Number: 05-24444
Type: Proposed Rule
Date: 2005-12-27
Agency: Department of Health and Human Services, Health Resources and Services Administration
This notice sets forth the Secretary's proposal to require HTPC grant recipients to contribute non-Federal matching funds in years 2 through 5 of the project period equal to two times the amount of the Federal Grant Award or such lesser amount determined by the Secretary for good cause shown.
Oral Dosage Form New Animal Drugs; Furosemide
Document Number: 05-24440
Type: Rule
Date: 2005-12-27
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of an abbreviated new animal drug application (ANADA) filed by First Priority, Inc. The ANADA provides for oral use of furosemide syrup for the treatment of edema in dogs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.